Duration of disease-modifying treatment impacts disability outcomes in MS
Longer exposure to disease-modifying treatment delayed the time to wheelchair use among patients with primary progressive MS, or PPMS, according to findings presented at MSVirtual2020.Additionally, treating younger patients — and a decrease in the delay of time to treatment — improved patients’ long-term disability outcomes, study findings showed.
#NDIS #shufflernews #NDISSoletrader
Another NDIS Sole Trader Initiative
Unfunded, unsponsored and UNREAL
This post was originally published on this site NDIS News Feed Rss.app https://rss.app/feeds/a9qJtTN0lY5uESwx.xml